
HealthTech Capital
Description
HealthTech Capital, established in 2010 and based in Los Altos Hills, California, operates as a specialized group of private investors dedicated to fostering innovation within the burgeoning health technology sector. This angel syndicate primarily targets early-stage startups that are developing groundbreaking technologies aimed at enhancing healthcare delivery and improving patient outcomes. Their investment philosophy emphasizes not only capital infusion but also active mentorship, leveraging the collective expertise of their members to guide portfolio companies through critical growth phases.
The firm's investment strategy is characterized by a focus on companies with a working prototype that are poised to raise their initial institutional funding rounds. HealthTech Capital typically deploys first checks ranging from $250,000 to $1 million, often participating in syndicated rounds alongside other angel groups or venture capital firms. This collaborative approach allows them to support larger funding initiatives while maintaining their early-stage focus. Their portfolio reflects a commitment to diverse health tech solutions, spanning areas suchs as digital health platforms, remote monitoring, and data analytics in healthcare.
Over the years, HealthTech Capital has built a robust portfolio of over 30 investments, including several companies that have achieved significant milestones. Notable exits and successes include their early support for Livongo Health, which was later acquired by Teladoc, and investments in prominent digital health companies like Omada Health and Propeller Health. These examples underscore HealthTech Capital's ability to identify and back promising ventures that have gone on to make substantial impacts in the healthcare landscape, solidifying their reputation as a key player in early-stage health tech funding.
Investor Profile
HealthTech Capital has backed more than 91 startups, with 0 new investments in the last 12 months alone. The firm has led 10 rounds, about 11% of its total and boasts 10 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Seed, Series A, Convertible Note rounds (top funding stages).
- Majority of deals are located in United States, Canada.
- Strong thematic focus on Health Care, Medical Device, Medical.
- Typical check size: $250K – $1M.
Stage Focus
- Seed (32%)
- Series A (26%)
- Convertible Note (23%)
- Series B (8%)
- Series Unknown (5%)
- Pre Seed (2%)
- Undisclosed (1%)
- Grant (1%)
- Post Ipo Equity (1%)
Country Focus
- United States (99%)
- Canada (1%)
Industry Focus
- Health Care
- Medical Device
- Medical
- Biotechnology
- Health Diagnostics
- Wellness
- Software
- Personal Health
- Artificial Intelligence (Ai)
- Fitness
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.